|
Mechanism5-HT1A receptor agonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Cepa Schwarz Pharma Sl
0 Patents (Medical) associated with Cepa Schwarz Pharma Sl
100 Deals associated with Cepa Schwarz Pharma Sl
100 Translational Medicine associated with Cepa Schwarz Pharma Sl